Vanderbilt University’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Sell
18,454
-30,290
-62% -$601K 0.05% 66
2026
Q1
$937K Buy
48,744
+261
+0.5% +$5.14K 0.18% 50
2025
Q4
$918K Buy
+48,483
New +$899K 0.16% 50
2025
Q2
Sell
-70,388
Closed -$1.23M 85
2025
Q1
$1.23M Sell
70,388
-10,302
-13% -$174K 0.23% 50
2024
Q4
$1.4M Sell
80,690
-7,792
-9% -$142K 0.27% 48
2024
Q3
$1.65M Buy
+88,482
New +$1.49M 0.3% 47
2023
Q4
Sell
-10,468
Closed -$146K 65
2023
Q3
$146K Sell
10,468
-3,290
-24% -$42.1K 0.04% 52
2023
Q2
$162K Buy
+13,758
New +$157K 0.04% 44
2023
Q1
Sell
-15,621
Closed -$194K 49
2022
Q4
$194K Buy
+15,621
New +$199K 0.05% 35
2022
Q1
Sell
-71,775
Closed -$972K 45
2021
Q4
$972K Buy
71,775
+49,810
+227% +$705K 0.2% 29
2021
Q3
$323K Buy
+21,965
New +$371K 0.08% 39

Other funds holding SBRA

Vanderbilt University's SBRA Position: Q2 2026 in Review

Vanderbilt University reduced its Sabra Healthcare REIT (SBRA) stake by 62% in Q2 2026, selling an estimated $601K and leaving 18,454 shares worth $360K. The position accounts for 0.05% of the portfolio, ranked #66.

Vanderbilt University first reported a position in SBRA in Q3 2021 and has held it in 11 quarters since. The position peaked at $1.65M in Q3 2024. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Vanderbilt University held 18,454 shares of Sabra Healthcare REIT worth $360K as of Q2 2026.
  • Vanderbilt University sold 30,290 Sabra Healthcare REIT shares in Q2 2026, an estimated $601K.
  • Sabra Healthcare REIT made up 0.05% of Vanderbilt University's portfolio in Q2 2026, its #66 holding.
  • Vanderbilt University first reported a position in Sabra Healthcare REIT in Q3 2021 and has held it in 11 quarters since.
  • Vanderbilt University's Sabra Healthcare REIT position peaked at $1.65M in Q3 2024.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Vanderbilt University's 13F filing for Q2 2026, filed 22 Jul 2026.